The PE-GenieFluor 594 Anti-Mouse CD19 Antibody (1D3) (AGEL3169) from AssayGenie is a cutting-edge tool for researchers studying the CD19 protein in mouse models. This high-quality antibody, directly conjugated with PE-GenieFluor 594, offers exceptional sensitivity and specificity in flow cytometry and immunofluorescence applications.CD19 is a critical marker for B cells and plays a key role in various immune responses. The 1D3 antibody specifically targets CD19, allowing for precise identification and quantification of B cells in experimental settings.
Whether investigating normal immune function, B cell development, or disease progression, this antibody provides reliable results and clear visualization of CD19-expressing cells.With its superior performance and reliability, the PE-GenieFluor 594 Anti-Mouse CD19 Antibody (1D3) (AGEL3169) is a valuable tool for immuno-oncology, immunology, and vaccine development research. Trust AssayGenie for innovative solutions that drive scientific discovery forward.
PE/Genie Fluor 594 Rat IgG2a, κ Isotype Control[2A3]
Form:
Liquid
Conjugation:
PE/Genie Fluor594
Recommended Use:
Each lot of this antibody is quality control tested by flow cytometric analysis. Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use. We suggest each investigator should titrate the reagent to obtain optimal results [The recommended concentration is 0.1-1 μg/106 cells in 100 μL volume].
Spectrum:
Swissprot:
P25918
Gene ID:
12478
Storage Buffer:
Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant.
Stability & Storage:
Keep as concentrated solution. Store at 2~8°C and protected from prolonged exposure to light. Do not freeze. Centrifuge before opening to ensure complete recovery of vial contents. This product is guaranteed up to one year from purchase.
Background:
CD19 is a 95 kD glycoprotein also known as B4. It is a member of the Ig superfamily, expressed on all pro-B to mature B cells (during development) and follicular dendritic cells. Plasma cells do not express CD19. CD19, in association with CD21 and CD81, forms a molecular complex integral to B cell activation.